The Role of WSB1 in Tumorigenesis
The Role of WSB1 in Tumorigenesis
批准号:
8786949
负责人:
Zhenkun Lou
金额:
$32.99万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-09-01 至 2019-08-31
关键词:
Animal ModelBiochemicalCell Cycle ProgressionCellsDNA DamageDevelopmentDown-RegulationEnergy MetabolismEventGlycolysisHumanKnockout MiceMalignant NeoplasmsMalignant neoplasm of pancreasMetabolicMetabolismMusMutationOncogenesOncogenicOrganismPathway interactionsPhenotypePlayRegulationRoleSignal PathwayTestingUp-RegulationXenograft Modelbasecell transformationhypoxia inducible factor 1malignant breast neoplasmmelanomamouse modelnoveloverexpressionpublic health relevanceresponsesenescencetumortumor progressiontumorigenesisubiquitin-protein ligase
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Many oncogenes such as Ras induce senescence-like phenotypes termed oncogene-induced senescence (OIS). It is well established that OIS is a barrier of tumorigenesis, and OIS has to be suppressed for cells to be transformed by oncogenes. However, how OIS is suppressed during cell transformation remains unclear. In addition to suppressing OIS, oncogenes have to reprogram cellular metabolism to glycolysis to facilitate tumorigenesis and cancer progression. One of the major mechanism by which Ras induce metabolic reprograming is through upregulation of hypoxia-inducible factor 1 (HIF1). It is also unclear how Ras upregulates HIF1. We recently found that the E3 ubiquitin ligase subunit WSB1 plays a role in suppressing OIS and promoting metabolic reprogramming downstream of Ras. WSB1 is overexpressed in several human cancers including breast cancer, pancreatic cancer and melanoma. We show that WSB1 is upregulated by oncogenic Ras and Myc, and expression of WSB1 in primary MEFs expressing oncogenic Ras contributes to the suppression of OIS, leading to abnormal proliferation and cell transformation. Conversely, WSB1 downregulation promotes OIS. Mechanistically, we found that WSB1 negatively regulates ATM, which is important for inducing OIS. In addition, we found that WSB1 upregulates HIF1? and promotes metabolic phenotypes consistent with increased glycolysis. We hypothesize that WSB1 is a key player in early oncogenic events to i) suppress the DNA damage response and OIS through ATM degradation and ii) promote metabolic reprogramming through the HIF1 pathway. To test this hypothesis, we propose the following specific aims: 1. Study the regulation of ATM, the DNA damage response and OIS by WSB1; 2. Study the regulation of HIF1? by WSB1; 3. Generate WSB1 knockout mice to study the role of WSB1 in cancer development and progression. These studies will elucidate both a new factor that contributes to Ras induced tumorigenesis and a novel mechanism by which OIS is suppressed and metabolic reprogramming is induced. Because oncogenic Ras plays an important role in tumorigenesis in a variety of human cancers, our study will have significant impact on current understanding of the cause and progression of human cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ATR: targeting mechanical stress induced EMT and immune suppression in triple negative breast cancer
-
批准号:10658429
-
项目类别:
-
资助金额:$36.92万
-
财政年份:2023
-
负责人:Zhenkun Lou
-
依托单位:
Sensitizing Ovarian Cancer To PARP inhibitor and platinum treatment
-
批准号:10305524
-
项目类别:
-
资助金额:$36.37万
-
财政年份:2021
-
负责人:Zhenkun Lou
-
依托单位:
Sensitizing Ovarian Cancer To PARP inhibitor and platinum treatment
-
批准号:10415197
-
项目类别:
-
资助金额:$35.64万
-
财政年份:2021
-
负责人:Zhenkun Lou
-
依托单位:
Sensitizing Ovarian Cancer To PARP inhibitor and platinum treatment
-
批准号:10610944
-
项目类别:
-
资助金额:$35.64万
-
财政年份:2021
-
负责人:Zhenkun Lou
-
依托单位:
The role of nuclear PD-L1 in breast tumor cell division, progression and therapy response
-
批准号:10553119
-
项目类别:
-
资助金额:$35.64万
-
财政年份:2020
-
负责人:Zhenkun Lou
-
依托单位:
The role of nuclear PD-L1 in breast tumor cell division, progression and therapy response
-
批准号:10361225
-
项目类别:
-
资助金额:$35.64万
-
财政年份:2020
-
负责人:Zhenkun Lou
-
依托单位:
The role of nuclear PD-L1 in breast tumor cell division, progression and therapy response
-
批准号:9897018
-
项目类别:
-
资助金额:$36.37万
-
财政年份:2020
-
负责人:Zhenkun Lou
-
依托单位:
Regulation of Necroptosis and inflammation
-
批准号:10534748
-
项目类别:
-
资助金额:$35.64万
-
财政年份:2019
-
负责人:Zhenkun Lou
-
依托单位:
Regulation of Necroptosis and inflammation
-
批准号:10316176
-
项目类别:
-
资助金额:$35.64万
-
财政年份:2019
-
负责人:Zhenkun Lou
-
依托单位:
UFM1 signaling in DNA damage response and cancer therapy
-
批准号:10304188
-
项目类别:
-
资助金额:$35.64万
-
财政年份:2017
-
负责人:Zhenkun Lou
-
依托单位:
UFM1 signaling in DNA damage response and cancer therapy
-
批准号:10057359
-
项目类别:
-
资助金额:$36.37万
-
财政年份:2017
-
负责人:Zhenkun Lou
-
依托单位:
UFM1 signaling in DNA damage response and cancer therapy
-
批准号:9406523
-
项目类别:
-
资助金额:$36.37万
-
财政年份:2017
-
负责人:Zhenkun Lou
-
依托单位:
Regulation of homologous recombination and cancer cell response to chemoradiotherapy
-
批准号:9055788
-
项目类别:
-
资助金额:$36.37万
-
财政年份:2015
-
负责人:Zhenkun Lou
-
依托单位:
The Role of WSB1 in Tumorigenesis
-
批准号:9125795
-
项目类别:
-
资助金额:$32.99万
-
财政年份:2014
-
负责人:Zhenkun Lou
-
依托单位:
The Role of WSB1 in Tumorigenesis
-
批准号:9330110
-
项目类别:
-
资助金额:$32.99万
-
财政年份:2014
-
负责人:Zhenkun Lou
-
依托单位:
Regultion of p53 Deubiquitination
-
批准号:8206756
-
项目类别:
-
资助金额:$32.72万
-
财政年份:2011
-
负责人:Zhenkun Lou
-
依托单位:
Regultion of p53 Deubiquitination
-
批准号:8775203
-
项目类别:
-
资助金额:$32.72万
-
财政年份:2011
-
负责人:Zhenkun Lou
-
依托单位:
Regultion of p53 Deubiquitination
-
批准号:8588904
-
项目类别:
-
资助金额:$31.74万
-
财政年份:2011
-
负责人:Zhenkun Lou
-
依托单位:
Regultion of p53 Deubiquitination
-
批准号:8408814
-
项目类别:
-
资助金额:$30.76万
-
财政年份:2011
-
负责人:Zhenkun Lou
-
依托单位:
Regultion of p53 Deubiquitination
-
批准号:8037330
-
项目类别:
-
资助金额:$32.72万
-
财政年份:2011
-
负责人:Zhenkun Lou
-
依托单位:
海外基金